The US Food and Drug Administration (FDA) has awarded breakthrough device designation to...
- MDW, Longenesis and Bitfury to bring blockchain to medical imaging
- FDA grants breakthrough designation to BioDirection Tbit System
- What does the future hold for MRI? Find out in the latest issue of Medical Technology
- Exploring the past and future of MRI with Avingtrans
- How are emerging AI systems revolutionising the way that patients are treated? Find out in the latest issue of Medical Technology
MDW, Longenesis and Bitfury to bring blockchain to medical imaging
Radiology solutions provider Medical Diagnostic Web (MDW) has partnered with Longenesis and Bitfury Group to implement a healthcare blockchain technology across its marketplace.
FDA grants breakthrough designation to BioDirection Tbit System
The US Food and Drug Administration (FDA) has awarded breakthrough device designation to medical device firm BioDirection’s Tbit System developed to predict positive computerised tomography (CT) scans after traumatic brain injury (TBI).
What does the future hold for MRI? Find out in the latest issue of Medical Technology
In this issue: Detecting language problems in children, democratising patient data, aiding sepsis care, the future of MRI and more.
Exploring the past and future of MRI with Avingtrans
To further enhance its status in the MRI space, Avingtrans has acquired Tecmag, a US-based company, which designs and manufacturers consoles and probes for MRI and NMR probs. In the context of this acquisition, Peter Penfold, Avingtrans’ business development director, discussed how the company entered and then consolidated itself in the medical imaging space, as well as industry-wide challenges, innovations and areas predicted to drive growth.
Could a new Alzheimer’s blood test disrupt imaging and spinal fluid methods?
Finding a biomarker in Alzheimer's disease (AD) that translates into clinical meaningfulness has been a real challenge for the field of biomarkers in the central nervous system (CNS). The current way to definitively diagnose AD is through brain scans and tests of cerebrospinal fluid (CSF) that must be collected via lumbar puncture, but these procedures are invasive and expensive.
How are emerging AI systems revolutionising the way that patients are treated? Find out in the latest issue of Medical Technology
In this issue: 3D-printed anatomical models, robotic drug delivery, AI regulation, plus the latest comment and analysis from GlobalData’s healthcare experts.
Siemens Healthineers’ ARTIS pheno Angiography System
The ARTIS pheno angiography system is a robot-assisted device that is classified under the interventional fluoroscopic X-ray system by the US Food and Drug Administration (FDA).
Medical imaging firm Enlitic secures investment from Marubeni
US-based image diagnosis system developer Enlitic has secured investment from Japanese conglomerate Marubeni to support the development and commercialisation of its new device.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.